Upregulation of NPAS2, an alternative heterodimer to the BMAL1 partner, in some HCC tumors is associated with enhanced expression of CDC25A, which dephosphorylates cyclin-dependent kinases, promoting cell proliferation and inhibiting mitochondria-dependent intrinsic apoptosis. The gene discussed is BMAL1; the disease is hepatocellular carcinoma.